Abstract
Introduction

The development of cancer results from dysregulated proliferation or an incompetence of cells to undergo apoptotic cell death. Hence, an important issue emerging in drug discovery is
to target anticancer treatments on cell cycle checkpoints that are responsible for the control of cell cycle phase progression or on apoptosis, eliminating defective cells [1] . Because damage to DNA might be the common underlying mechanism for the positive outcome of chemotherapy, reactive oxygen species (ROS)-generating anticancer drugs have raised clinical interest [2, 3] . In response to DNA damage, the G2 checkpoint is activated to halt cell cycle progression, preventing cells from entering mitosis. Its activation proceeds through maintenance of the Thr14/Tyr15 inhibitory phosphorylations on cdc2, realized by the protein kinases Wee1 and Myt1, respectively [4, 5] . # These authors contributed equally. [6] [7] [8] [9] . Activated Chk1 phosphorylates the dual specificity phosphatase cdc25C on Ser216, thus creating a binding site for 14-3-3 proteins [10] . protein complexes are sequestered in the cytoplasm, thereby preventing cdc25C from activating cdc2 through removal of the inhibitory phosphorylations. This results in the maintenance of the cdc2-cyclin B1 complex in its inactive state and blocks entry into mitosis [11] . Conceptually, besides checkpoint initiation, the delay comprises two additional phases: maintenance during repair and termination to allow cell cycle progression. As much information has been gained regarding the signalling pathways involved in establishing a G2 checkpoint arrest, novel studies focus on the question of how checkpoint signalling is maintained [12] and overcome to allow cell cycle re-entry [13, 14] , especially if the drug is removed. p53 plays a critical role in maintaining G2 checkpoint arrest. At least one half of the tumours are p53-deficient, and some also show mutations or altered expressions of other components of the G2 checkpoint [15] . With this, induction of mitotic catastrophe as a result of checkpoint deficiency appears to be a desirable goal in cancer treatment [16] . In addition, permanently arresting tumour cell growth through the induction of senescence also seems to be an attractive treatment approach [17, 18] .
ATR indirectly modulates the phosphorylation status of these sites by activating the downstream protein kinase Chk1 via phosphorylation on Ser317 and Ser345
Collectively, senescence [19] [20] [21] and mitotic catastrophe [22, 23] are two major effects desired in drug treatment, although many studies report a separate role of Chk1 in DNA damage response [24, 25] 
Western blotting
Proteins were prepared as described previously [26] . (Fig. 5B) .
Remarkably, the late expression (72 hrs) of G1 arrest-associated pp53
Ser15
, p21 WAF1 and cyclin D1 was significantly reduced following Chk1 knockdown (Fig. 5B) . Consequently, as G1 arrest was shown to be Chk1 dependent (Fig. 1B) , Chk1 knockdown reverses the senescent phenotype of wt cells (Fig. 5E) . Interestingly, abrogation of G1 arrest at 72 hrs was accompanied by increased Pre-G1 cell population (Fig. 1B) 
Fig. 4 Analysis of establishment and override of Chk1-dependent G2 checkpoint arrest in HCT116 p21 -/-cells. (A) H2O2 treatment (30 mM, 3 min.) induces establishment of G2 checkpoint arrest in p21 -/-cells via the Chk1 pathway. H2O2 also induces apoptosis as indicated by the expression level of cleaved caspase 3. Whole cell lysates were subjected to Western blot analysis. ␤-actin was used to control protein loading. Fold expression changes are given below the blots. (B) G2 checkpoint override causes increased Chk1-dependent apoptosis as indicated by Pre-G1 cell population. FACS analyses were performed at 24, 48 and 72 hrs after treatment. Twenty-four hours after transfection with Chk1 siRNA, cells were treated with 30 mM H2O2 for 3 min. and grown for 24, 48 or 72 hrs. A control siRNA was used as a negative control for targeted siRNA transfection. Differentially gated cell populations were counted; their percentage in the total cell populations was calculated and presented in the diagram. The dashed line contributes to cell cycle analysis without H2O2 treatment to mark H2O2-induced G2 arrest as well as abrogation of G2 arrest following Chk1 siRNA transfection. Data are means of three independent experiments. (C) H2O2 treatment alters expression of cell cycle regulatory proteins in p21 -/-cells. Whole cell lysates were subjected to Western blot analysis. ␤-actin was used to control protein loading. Fold expression changes are given below the blots. (D) Analysis of cyclin B1 localization 24 hrs after H2O2 revealed its dominant nuclear localization in p21 -/-cells (late G2 arrest). Cells were fixed and subsequently stained with anti-cyclin B1 and counterstained with DAPI.
respectively (Fig. 6B) Banáth et al. [39] , the inability of the comet assay to detect significant DNA damage at 48 and 72 hrs after H2O2 (Fig. S1) suggests that many residual ␥-H2AX foci may not be associated with a physical break. 
Timing of the upstream Chk1-involved G 2 arrest impacts on long-term DNA damage responses
